FindTrial
Sign In

Prevalence of hand signs in myelopathy

To study the prevalence of hand signs in cervical spondylotic myelopathy: A prospective cohort analysis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072586
Enrollment
100
Registered
2024-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G992- Myelopathy in diseases classifiedelsewhere Health Condition 2: M471- Other spondylosis with myelopathy

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Stavya Spine Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed with cervical myelopathy at our Centre from 1ST Aug 2024 ââ?¬â?? 1ST Jan 2024.

Exclusion criteria

Exclusion criteria: Major neurodegenerative diseases such as 1.Alzheimerââ?¬•s or multiple sclerosis 2.Peripheral or vascular neuropathy 3.Spinal tumours or trauma 4.Tremor 5.Diabetes ââ?¬Â¢ Systemic rheumatological disease ââ?¬Â¢ History of spinal surgery

Design outcomes

Primary

MeasureTime frame
This will help in the diagnosis of cervical myelopathyTimepoint: This is a single point study requiring no further follow up or clinic visits from the patient—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Raviranjan Rai

Stavya Spine Hospital And Research Institute

drravirai84@gmail.com9726820898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026